Medicare Enrolled

Dr. Christopher Pace, MD

Urology Physician · Grapevine, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3600 WILLIAM D TATE AVE STE 200, Grapevine, TX 76051
8663678768
In practice since 2005 (20 years)
NPI: 1912993080 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pace? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pace

Dr. Christopher Pace is an urology physician in Grapevine, TX, with 20 years in practice. Based on federal Medicare data, Dr. Pace performed 2,100 Medicare services across 1,627 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pace received a total of $3,392 from 41 pharmaceutical and/or device companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pace is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 47% volume in TX$ $3,392 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,100
Medicare services
Top 47% in TX for urology physician
1,627
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Automated urinalysis423$2$5
Office visit, established patient (30-39 min)383$87$281
Bladder ultrasound after voiding243$8$24
New patient office visit (45-59 min)147$115$360
Blood draw (venipuncture)85$7$14
PSA test (prostate cancer screening)83$18$41
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique69$69$314
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional49$18$51
Hospital follow-up visit, moderate complexity48$61$164
Yeast/candida DNA test46$34$355
Detection test by nucleic acid for herpes simplex virus, amplified probe technique46$34$197
Infectious disease DNA/RNA test46$34$117
Office visit, established patient (20-29 min)40$65$210
Psa (prostate specific antigen) measurement, free36$18$41
Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes29$20$61
Insertion of stent in ureter using an endoscope28$119$1,113
Diagnostic exam of bladder and urethra using an endoscope23$179$523
Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique23$34$78
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique23$34$78
Detection test by nucleic acid for herpes virus-6, amplified probe technique23$34$78
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique23$34$78
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique23$34$78
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique23$34$78
Initial hospital admission, high complexity22$136$391
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes22$11$31
Testosterone (hormone) level, total18$25$57
Initial hospital admission, moderate complexity18$102$289
Urinalysis, manual17$3$8
New patient office visit (30-44 min)16$67$242
Office visit, established patient, complex (40-54 min)13$132$405
Imaging of urinary tract following injection of a contrast agent12$19$164
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
12.1% medium
86.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,392
Total received (2018-2024)
Avg $485/year across 7 years
Top 48% in TX for urology physician
41
Companies
145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,182 (93.8%)
Scientific / Research
Research funding and grants
$210 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$777
2023
$710
2022
$476
2021
$341
2020
$263
2019
$416
2018
$410

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$408
ABBVIE INC.
$316
PFIZER INC.
$310
Boston Scientific Corporation
$273
Janssen Biotech, Inc.
$211
Axonics, Inc.
$165
BOSTON SCIENTIFIC CORPORATION
$127
Coloplast Corp
$122
Blue Earth Diagnostics Limited
$118
Olympus America Inc.
$100
Endo Pharmaceuticals Inc.
$99
ACCORD HEALTHCARE, INC.
$95
Endo USA, Inc.
$88
Sumitomo Pharma America, Inc.
$83
Merck Sharp & Dohme LLC
$71
Janssen Scientific Affairs, LLC
$70
COLOPLAST CORP
$64
UroGen Pharma, Inc.
$63
Ferring Pharmaceuticals Inc.
$61
MEDIVATION FIELD SOLUTIONS LLC
$59
UROGEN PHARMA, INC.
$44
AbbVie Inc.
$36
TherapeuticsMD, Inc.
$36
AbbVie, Inc.
$36
Kowa Pharmaceuticals America, Inc.
$34
Antares Pharma, Inc.
$31
Verity Pharmaceuticals Inc.
$27
PROGENICS PHARMACEUTICALS, INC.
$25
Accord Healthcare, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Myovant Sciences Inc.
$20
Progenics Pharmaceuticals, Inc.
$20
Biocomposites Inc
$19
Avadel Specialty Pharmaceuticals, LLC
$18
Supernus Pharmaceuticals, Inc.
$18
Amgen Inc.
$16
TOLMAR Pharmaceuticals, Inc.
$15
Tolmar, Inc.
$14
GENZYME CORPORATION
$14
ACELL, INC.
$12
180 Medical, Inc.
$11
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
ANNOVERA · AVEED · Axonics · Axumin · BOTOX · Bulkamid · CAMCEVI · Coloplast TFL Drive · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · General - Therapies · Isiris · Isiris aStent Removal Device · JELMYTO · JEVTANA · KEYTRUDA · Kyleena · LO LOESTRIN FE · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · POSLUMA · PYLARIFY · Prolia · ReTrace · Rezum Generator · SEGLENTIS · Stenostent · Stimulan · Trelstar · URETERO-RENO FIBERSCOPE · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $162 per 100 Medicare services performed
Looking for a urology physician in Grapevine?
Compare urology physicians in the Grapevine area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
180
Per 100K population
8.4
County median income
$81,905
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pace is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pace experienced with automated urinalysis?
Based on Medicare claims data, Dr. Pace performed 423 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pace receive payments from pharmaceutical companies?
Yes. Dr. Pace received a total of $3,392 from 41 companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pace's costs compare to other urology physicians in Grapevine?
Dr. Pace's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →